Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Aziz completed his pediatric cardiology fellowship at the Children's Hospital of Philadelphia in 2010 and continued his training there in pediatric electrophysiology. During his fellowship, Dr. Aziz was awarded a training grant under the National Institute of Health (NIH) to investigate genotype and phenotype correlations in pediatric patients with long QT syndrome. Dr. Aziz also acquired skills in catheter ablation of pediatric arrhythmias and device (pacemaker and ICD) implantation. Following his fellowship, Dr. Aziz joined the Cleveland Clinic as a pediatric electrophysiologist. He is active in the training and teaching of medical students, residents and fellows, an activity that continuously inspires him. Dr. Aziz is also quite active in research and was the recent recipient of the SADS 2011 Young Investigator Award for his work on long QT syndrome.
Dr Aziz acquired skills in Catheter Ablation of pediatric arrhythmias and device implantation which is a regular part of his clinical practice.
Following his fellowship training, Dr. Aziz joined the Cleveland Clinic as a pediatric electrophysiologist. Since joining as a staff physician Dr. Aziz has been awarded “Lecturer of the Year” consecutively since his appointment. He is active in the training and teaching of medical students, residents and fellows, an activity that continuously inspires him. Recently, Dr. Aziz was appointed the Director of the Sir Magdi Yacoub International Fellowship in Pediatric Cardiology. This program is aimed at providing subspecialty training to international physicians who will return home to provide needed care to under-served pediatric patients with congenital heart disease and inherited arrhythmia disorders.
Dr. Aziz has been an invited lecturer on several occasions for his expertise in sudden cardiac death and inherited arrhythmias, which continues to be his academic and clinical passion. He is the first and current Director of the Inherited Arrhythmias Clinic, an effort that was proposed, initiated and established through his fervor in managing the channelopathy syndromes. Dr. Aziz looks forward to participating in the ever changing field of electrophysiology and hopes to constantly improve the outcomes of patients with inherited arrhythmia syndromes.
Abnormal heart rhythms, arrhythmogenic right ventricular dysplasia, heart palpitations, long QT syndrome (LQTS), supraventricular tachycardia, syncope, ventricular tachycardia, Wolff-Parkinson-White Syndrome (WPW), electrophysiology study, radiofrequency ablation, device implantation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/3/2016, Dr. Aziz has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.